Long-term prognosis of diabetic patients with critical limb ischemia: a population-based cohort study
- PMID: 19223609
- PMCID: PMC2671089
- DOI: 10.2337/dc08-1223
Long-term prognosis of diabetic patients with critical limb ischemia: a population-based cohort study
Erratum in
- Diabetes Care. 2009 Jul;32(7):1355. Luppattelli, Tommaso [corrected to Lupattelli, Tommaso]
Abstract
Objective: To evaluate the long-term prognosis of critical limb ischemia (CLI) in diabetic patients.
Research design and methods: A total of 564 consecutive diabetic patients were hospitalized for CLI from January 1999 to December 2003; 554 were followed until December 2007.
Results: The mean follow-up was 5.93 +/- 1.28 years. Peripheral angioplasty (PTA) was performed in 420 (74.5%) and bypass graft (BPG) in 117 (20.6%) patients. Neither PTA nor BPG were possible in 27 (4.9%) patients. Major amputations were performed in 74 (13.4%) patients: 34 (8.2%) in PTA, 24 (21.1%) in BPG, and 16 (59.2%) in a group that received no revascularization. Restenosis occurred in 94 patients, bypass failures in 36 patients, and recurrent ulcers in 71 patients. CLI was observed in the contralateral limb of 225 (39.9%) patients; of these, 15 (6.7%) required major amputations (rate in contralateral compared with initial limb, P = 0.007). At total of 276 (49.82%) patients died. The Cox model showed significant hazard ratios (HRs) for mortality with age (1.05 for 1 year [95% CI 1.03-1.07]), unfeasible revascularization (3.06 [1.40-6.70]), dialysis (3.00 [1.63-5.53]), cardiac disease history (1.37 [1.05-1.79]), and impaired ejection fraction (1.08 for 1% point [1.05-1.09]).
Conclusions: Diabetic patients with CLI have high risks of amputation and death. In a dedicated diabetic foot center, the major amputation, ulcer recurrence, and major contralateral limb amputation rates were low. Coronary artery disease (CAD) is the leading cause of death, and in patients with CAD history the impaired ejection fraction is the major independent prognostic factor.
Figures
References
-
- Orchard TJ, Strandness DE: Assessment of peripheral vascular disease in diabetes. Report and Recommendations of an International Workshop sponsored by the American Heart Association and the American Diabetes Association. Diabetes Care 1993; 16: 1199– 1209 - PubMed
-
- American Diabetes Association. Peripheral arterial disease in people with diabetes. Diabetes Care 2003; 26: 333– 341 - PubMed
-
- Marso SP, Hiatt WR: Peripheral arterial disease in patients with diabetes. J Am Coll Cardiol 2005; 47: 921– 929 - PubMed
-
- TransAtlantic Inter-Society Consensus (TASC). Management of peripheral arterial disease (PAD). Eur J Vasc Endovasc Surg 2000; 19 ( Suppl. A): S208– S290 - PubMed
-
- Faglia E, Dalla Paola L, Clerici G, Clerissi J, Graziani L, Fusaro M, Gabrielli L, Losa S, Stella A, Gargiulo M, Mantero M, Caminiti M, Ninkovic S, Curci V, Morabito A: Peripheral angioplasty as the first-choice revascularization procedure in diabetic patients with critical limb ischemia: prospective study of 993 consecutive patients hospitalized and followed between 1999 and 2003. Eur J Vasc Endovasc Surg 2005; 29: 620– 627 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
